Ezutromid is an aryl hydrocarbon receptor antagonist that upregulates the production of utrophin, a dystrophin paralogue, and reverses DMD pathology in mdx mice (Tinsley et al., 1998). Here, AHR is linked to Duchenne muscular dystrophy.